Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Jerzy P Szaflarski Daniel Friedman Chloe Verducci Orrin Devinsky |
| Publication date | July 11, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |